Melinta Therapeutics Inc (MLNTQ)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: MLNTQ Exchange: OTC


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2019-07-02 2019-06-27 S Sale

JOHNSON JOHN

Chief Executive Officer

Executive Director
13,000 -25.8%
5.57
72,441 USD 		13,000 -25.8% 5.57 72,441 USD
2018-05-31 2018-05-29 B Purchase

Duffy Erin

Chief Scientific Officer

Officer
4,000 +inf%
5.00
20,000 USD 		4,000 +inf% 5.00 20,000 USD
2018-05-31 2018-05-29 B Purchase

ZACCARDELLI DAVID

Non-Executive Director
40,000 +615.4%
5.00
200,000 USD 		40,000 +615.4% 5.00 200,000 USD
2018-05-31 2018-05-29 B Purchase

Wechsler Daniel Mark

See Remarks

Executive Director
50,000 +inf%
5.00
250,000 USD 		50,000 +inf% 5.00 250,000 USD
2018-05-31 2018-05-29 B Purchase

Cammarata Sue

Chief Medical Officer

Officer
4,000 +inf%
5.00
20,000 USD 		4,000 +inf% 5.00 20,000 USD
2018-05-31 2018-05-29 B Purchase

Estrem Paul

Chief Financial Officer

Officer
10,000 +inf%
5.00
50,000 USD 		10,000 +inf% 5.00 50,000 USD
2018-05-31 2018-05-29 B Purchase

Vatera Healthcare Partners LLC

Non-Executive Director Major owner
7,878,500 +90.3%
5.00
39,392,500 USD 		7,878,500 +90.3% 5.00 39,392,500 USD
2018-05-31 2018-05-29 B Purchase

Vatera Healthcare Partners LLC

Non-Executive Director Major owner
7,878,500 +90.3%
5.00
39,392,500 USD 		7,878,500 +90.3% 5.00 39,392,500 USD
2018-05-31 2018-05-29 B Purchase

Vatera Healthcare Partners LLC

Non-Executive Director Major owner
7,500,000 +88.2%
5.00
37,500,000 USD 		7,500,000 +88.2% 5.00 37,500,000 USD
2018-05-30 2018-05-25 B Purchase

GILL DAVID N

Non-Executive Director
5,000 +500.0%
6.09
30,450 USD 		5,000 +500.0% 6.09 30,450 USD
2018-01-09 2018-01-05 B Purchase

Vatera Healthcare Partners LLC

Non-Executive Director Major owner
2,000,000 +29.7%
13.50
27,000,000 USD 		2,000,000 +29.7% 13.50 27,000,000 USD
2018-01-09 2018-01-05 B Purchase

Vatera Healthcare Partners LLC

Non-Executive Director Major owner
2,000,000 +29.7%
13.50
27,000,000 USD 		2,000,000 +29.7% 13.50 27,000,000 USD
2018-01-09 2018-01-05 B Purchase

Vatera Healthcare Partners LLC

Non-Executive Director Major owner
1,777,778 +26.4%
13.50
24,000,003 USD 		1,777,778 +26.4% 13.50 24,000,003 USD
2017-03-09 2017-03-08 S Sale

GOLDSTEIN DOV A MD

Non-Executive Director
99,900 -100.0%
3.57
356,443 USD 		99,900 -100.0% 3.57 356,443 USD
2017-03-09 2017-03-07 S Sale

GOLDSTEIN DOV A MD

Non-Executive Director
50,100 -33.4%
3.53
176,673 USD 		50,100 -33.4% 3.53 176,673 USD
2017-01-18 2017-01-13 S Sale

GOLDSTEIN DOV A MD

Non-Executive Director
105,460 -41.3%
3.40
358,564 USD 		105,460 -41.3% 3.40 358,564 USD
2017-01-06 2017-01-06 S Sale

GOLDSTEIN DOV A MD

Non-Executive Director
437,600 -63.1%
3.64
1,592,864 USD 		437,600 -63.1% 3.64 1,592,864 USD
2017-01-06 2017-01-05 S Sale

GOLDSTEIN DOV A MD

Non-Executive Director
500,000 -41.9%
3.20
1,600,000 USD 		500,000 -41.9% 3.20 1,600,000 USD
2017-01-04 2017-01-03 B Purchase

GILL DAVID N

Non-Executive Director
5,000 +inf%
2.94
14,720 USD 		5,000 +inf% 2.94 14,720 USD
2016-03-02 2016-03-01 B Purchase

Moore David

Chief Commercial Officer

Officer
500 +50.0%
16.18
8,090 USD 		500 +50.0% 16.18 8,090 USD
2016-01-06 2016-01-04 PS Planned sale

GOLDSTEIN DOV A MD

Non-Executive Director
842 -94.4%
30.06
25,314 USD 		842 -94.4% 30.06 25,314 USD
2015-12-15 2015-12-15 PS Planned sale

Oldach David W.

Chief Medical Officer

Officer
1,778 -61.8%
30.00
53,340 USD 		1,778 -61.8% 30.00 53,340 USD
2015-12-15 2015-12-11 PS Planned sale

Oldach David W.

Chief Medical Officer

Officer
8,222 -88.2%
30.33
249,373 USD 		8,222 -88.2% 30.33 249,373 USD
2015-11-12 2015-11-09 S Sale

Oldach David W.

Chief Medical Officer

Officer
2,200 -66.7%
28.78
63,316 USD 		2,200 -66.7% 28.78 63,316 USD
2015-11-12 2015-11-09 S Sale

Oldach David W.

Chief Medical Officer

Officer
10,000 -75.2%
28.78
287,800 USD 		10,000 -75.2% 28.78 287,800 USD
2015-10-27 2015-10-26 B Purchase

DOUGHERTY MICHAEL R

Non-Executive Director
2,000 +inf%
18.45
36,896 USD 		2,000 +inf% 18.45 36,896 USD
2015-10-26 2015-10-26 B Purchase

Kong Garheng

Non-Executive Director
2,830 +inf%
17.43
49,335 USD 		2,830 +inf% 17.43 49,335 USD
2015-06-24 2015-06-22 PS Planned sale

GOLDSTEIN DOV A MD

Non-Executive Director
50,000 -99.9%
35.74
1,787,000 USD 		50,000 -99.9% 35.74 1,787,000 USD
2015-05-27 2015-05-22 S Sale

Fernandes Prabhavathi

President and CEO

Executive Director
9,000 -3.5%
35.72
321,489 USD 		9,000 -3.5% 35.72 321,489 USD
2014-05-28 2014-05-23 B Purchase

JOHNSON JOHN

Non-Executive Director
10,000 +inf%
9.10
90,980 USD 		10,000 +inf% 9.10 90,980 USD
2013-08-01 2013-06-19 B Purchase

NEFF P SHERRILL

Non-Executive Director
265,000 +8.1%
7.00
1,855,000 USD 		265,000 +8.1% 7.00 1,855,000 USD
2013-08-01 2013-06-19 B Purchase

Quaker BioVentures II LP

Major owner
265,000 +8.1%
7.00
1,855,000 USD 		265,000 +8.1% 7.00 1,855,000 USD
2014-05-13 2013-05-09 B Purchase

Fernandes Prabhavathi

President and CEO

Executive Director
3,500 +1.7%
8.60
30,100 USD 		3,500 +1.7% 8.60 30,100 USD
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Major owner
1,025 +0.2%
6.00
6,150 USD 		1,025 +0.2% 6.00 6,150 USD
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Major owner
16,667 +3.5%
6.00
100,002 USD 		16,667 +3.5% 6.00 100,002 USD
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Major owner
1,025 +0.2%
6.00
6,150 USD 		1,025 +0.2% 6.00 6,150 USD
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Major owner
16,666 +3.6%
6.00
99,996 USD 		16,666 +3.6% 6.00 99,996 USD
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Major owner
1,025 +0.2%
6.00
6,150 USD 		1,025 +0.2% 6.00 6,150 USD
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Major owner
16,666 +3.3%
6.00
99,996 USD 		16,666 +3.3% 6.00 99,996 USD
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Major owner
1,025 +0.1%
6.00
6,150 USD 		1,025 +0.1% 6.00 6,150 USD
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Major owner
16,667 +2.3%
6.00
100,002 USD 		16,667 +2.3% 6.00 100,002 USD
2012-02-09 2012-02-08 B Purchase

Intersouth Associates VI, LLC

Major owner
732,989 +119.7%
6.00
4,397,934 USD 		732,989 +119.7% 6.00 4,397,934 USD
2012-02-09 2012-02-08 B Purchase

NEFF P SHERRILL

Non-Executive Director Major owner
1,189,805 +57.4%
6.00
7,138,830 USD 		1,189,805 +57.4% 6.00 7,138,830 USD
2012-02-09 2012-02-08 B Purchase

Intersouth Associates VI, LLC

Major owner
488,659 +33.0%
6.00
2,931,954 USD 		488,659 +33.0% 6.00 2,931,954 USD
2012-02-09 2012-02-07 B Purchase

Aisling Capital II LP

Major owner
1,213,663 +58.4%
6.00
7,281,978 USD 		1,213,663 +58.4% 6.00 7,281,978 USD
2012-02-09 2012-02-07 B Purchase

GOLDSTEIN DOV A MD

Non-Executive Director
1,213,663 +58.4%
6.00
7,281,978 USD 		1,213,663 +58.4% 6.00 7,281,978 USD